Interventions to optimise prescribing for older people in care homes

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 2, 2013, Pages

  Alldred, David P ^a   Raynor, David K ^a   Hughes, Carmel ^b   Barber, Nick ^c   Chen, Timothy F ^d   Spoor, Pat ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ARTICLE; CLINICAL DECISION SUPPORT SYSTEM; DATA BASE; DRUG COST; GROUPS BY AGE; HEALTH CARE FACILITY; HEALTH CARE UTILIZATION; HOME CARE; HOSPITAL ADMISSION; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; POTENTIALLY INAPPROPRIATE MEDICATION; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; SYSTEMATIC REVIEW;

EID: 84983535429     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009095.pub2     Document Type: Article

References (56)

1. Claesson CB, Schmidt IK. Drug use in Swedish nursing homes. Clinical Drug Investigation 1998;16(6):441-52.
2. Schmidt IK, Claesson CB, Westerholm B, Nilsson LG. Physician and staff assessments of drug interventions and outcomes in Swedish nursing homes. Annals of Pharmacotherapy 1998;32:27-32.
3. Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H, et al. An outreach geriatric medicine advisory service in residential aged care: a randomised controlled trial of case conferencing. Age and Ageing 2004;33:612-7.
4. Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. The American Journal of Geriatric Pharmacotherapy 2004;2(4):257-64.
5. Burns A, Furniss L, Cooke J, Lloyd Craig SK, Scobie S. Pharmacist medication review in nursing homes: a cost analysis. International Journal of Geriatric Psychopharmacology 2000;2:137-41.
6. Furniss L, Burns A, Craig SKL, Scobie S, Cooke J, Faragher B. Effect of a pharmacist's medication review in nursing homes: randomised controlled trial. The British Journal of Psychiatry 2000;176:563-7.
7. Furniss L, Craig S, Scobie S, Cooke J, Burns A. Medication reviews in nursing homes: documenting and classifying the activities of a pharmacist. Pharmaceutical Journal 1998;261 (7009):320-3.
8. Gurwitz JH, Field TS, Rochon P, Judge J, Harrold LR, Bell CM, et al. Effect of computerised provider order entry with clinical decision support on adverse drug events in the long-term care setting. Journal of the American Geriatrics Society 2008;56:2225-33.
9. Judge J, Field TS, DeFlorio M, Laprino J, Auger J, Rochon P, et al. Prescribers' responses to alerts during medication ordering in the long term care setting. Journal of the American Medical Informatics Association 2006;13:385-90.
10. Roberts M, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. British Journal of Clinical Pharmacology 2001;51:257-65.
11. Strikwerda P, Bootsma-De Langen AM, Berghuis F, Meyboom-de Jong B. Drug therapy in a nursing home; favorable effect of feedback by the pharmacist on family physician's prescribing behavior [Farmacotherapie in een verzorgingshuis; gunstige invloed van feed-back door de apotheker op het voorschrijfgedrag van de huisarts]. Nederlands Tijdschrift voor Geneeskunde 1994;138(35): 1770-4.
12. Alldred DP, Zermansky AG, Petty DR, Raynor DK, Freemantle N, Eastaugh J, et al. Clinical medication review by a pharmacist of elderly people living in care homes: pharmacist interventions. International Journal of Pharmacy Practice 2007;13:93-9. [DOI: 10.1211/ijpp.15.2.0003].
13. Zermansky AG, Alldred DP, Petty DR, Raynor DK, Freemantle N, Eastaugh J, et al. Clinical medication review by a pharmacist of elderly people living in care homes - randomised controlled trial. Age and Ageing 2006;35: 586-91.
14. Beer C, Potter K, Loh PK, Peng YG, Millar A. A pilot randomized controlled trial of deprescribing: Stopat (systematic termination of pharmaceutical agents trial). Basic and Clinical Pharmacology and Toxicology 2011;109: 156.
15. Lapane KL, Hughes CM, Daiello LA, Cameron, KA, Feinberg J. Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes. Journal of the American Geriatrics Society 2011;59(7): 1238-45.
16. Desborough J, Houghton J, Wood J, Wright D, Holland R, Sach T, et al. Multi-professional clinical medication reviews in care homes for the elderly: study protocol for a randomised controlled trial with cost effectiveness analysis. Trials 2011;12:218.
17. Alldred DP, Petty DR, Bowie P, Zermansky AG, Raynor DK. Antipsychotic prescribing patterns in care homes and relationship with dementia. Psychiatric Bulletin 2007;31(9): 329-32.
18. Alldred DP, Zermansky AG, Petty DR, Raynor DK, Freemantle N, Eastaugh J, et al. Clinical medication review by a pharmacist of elderly people living in care homes: Pharmacist interventions. International Journal of Pharmacy Practice 2007;15(2):93-9.
19. Armour D, Cairns C (editors) 2002. Medicines in the Elderly. London: The Pharmaceutical Press, 2002.
20. Barber ND, Alldred DP, Raynor DK, Dickinson R, Garfield S, Jesson B, et al. Care homes' use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older people. Quality and Safety in Health Care October 2009;18:341-6.
21. Beers MH, Ouslander JG, Fingold SF, Morgenstern H, Reuben DB, Rogers W, et al. Inappropriate medication prescribing in skilled nursing-home facilities. Annals of Internal Medicine 1992;117:684-9.
22. Beglinger. Ethics related to drug therapy in the elderly. Digestive Diseases 2008;26:28-31.
23. Brymer C, Borrie MJ, Crilly RG, Hindman D, Esbaugh J, Pavlakovic R, et al. Prevalence of and factors associated with potentially inappropriate prescribing in long-term care facilities. Journal of the Canadian Geriatric Society 2003;6: 146-52.
24. Christensen M, Lundh A.Medication review of hospitalized patients to prevent morbidity and mortality. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/14651858.CD008986]
25. Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H, et al.A n outreach geriatric medicine advisory service in residential aged care: a randomised controlled trial of case conferencing. Age and Ageing 2004;33:612-7.
26. Department of Health. National Service Framework for Older People. 2001.
27. Effective Practice and Organisation of Care group. EPOC resources for review authors. http://www.epoc.cochrane.org/ en/handsearchers.html 2009.
28. Faey T, Montgomery AA, Barnes J, Protheroe J. Quality of care for elderly residents in nursing homes and elderly people living at home: controlled observational study. BMJ 2003;326:580-4.
29. Furniss L, Burns A, Craig SKL, Scobie S, Cooke J, Faragher B. Effects of a pharmacist's medication review in nursing homes: randomised controlled trial. The British Journal of Psychiatry 2000;176:563-7.
30. GRADE. Grading of Recommendations Assessment, Development and Evaluation Working Group. http:// www.gradeworkinggroup.org/.
31. Gray SL, Hedrick SC, Rhinard EE, Sales AE, Sullivan JH, Tomatore JB, et al. Potentially inappropriate medication use in community residential care facilities. The Annals of Pharmacotherapy 2003;37:988-93.
32. Gurwitz JH, Field TS, Judge J, Rochon P, Harrold LR, Cadoret C, et al. The incidence of adverse drug events in two large academic long-term care facilities. The American Journal of Medicine 2005;118:251-8.
33. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. Journal of Clinical Epidemiology 1992;45(10):1045-51.
34. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, et al. A randomised controlled trial of a clinical pharmacist intervention with elderly outpatients with polypharmacy. American Journal of Medicine 1996; 100:428-37.
35. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Intervention. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1/http: //www.cochrane.org/resources/handbook. The Cochrane Collaboration, 2008.
36. Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, et al. Which drugs cause preventable admission to hospital? A systematic review. British Journal of Clinical Pharmacology 2007;63:136-47.
37. Kaur S, Mitchell G, Vitetta L, Roberts MS. Interventions that can reduce inappropriate prescribing in the elderly. Drugs & Aging 2009;26(12):1013-28.
38. LaMantia MA, Schernemann LP, Viera AJ, Busby-Whitehead J, Hanson LC. Interventions to improve transitional care between nursing homes and hospitals: a systematic review. Journal of the American Geriatrics Society 2010;58:777-82.
39. Lau DT, Kasper JD, Potter DEB, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Archives of Internal Medicine 2005; 165:68-74.
40. Lefebvre C,Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org, updated March 2011.
41. Longanathan M, Singh S, Dean Franklin B, Bottle A, Majeed A. Interventions to optimise prescribing in care homes: systematic review. Age and Ageing 2011;40:150-62.
42. Markum ZA, Handler SM, Wright R, Hanlon JT. Interventions to improve suboptimal prescribing in nursing homes: a narrative review. The American Journal of Geriatric Pharmacotherapy 2010;8(3):183-200.
43. Matthews FE, Dening T. Prevalence of dementia in institutional care. Lancet 2002;360:225-6.
44. Oborne CA, Hooper R, Swift GC, Jackson SD. Explicit, evidence-based criteria to assess the quality of prescribing to elderly nursing home residents. Age and Ageing 2003;32: 102-8.
45. Office for National Statistics. Ageing. http:// www.statistics.gov.uk/cci/nugget.asp?ID=949 2010.
46. Ostini R, Hegney D, Jackson C, Williamson M, Mackson JM, Gurman K, et al. Systematic review of interventions to improve prescribing. The Annals of Pharmacotherapy 2009; 43:502-12.
47. Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database of Systematic Reviews May 2012.
48. Perri M, Menon AM, Deshpande AD, Shinde SB, Cooper JW, Cook CL, et al. Adverse outcomes associated with inappropriate drug use in nursing homes. The Annals of Pharmacotherapy 2005;39:405-11.
49. The Nordic Cochrane Centre. Review Manager (RevMan). 5.0.25. 2008.
50. Rollason V, Vogt N. Reduction of polypharmacy in the elderly. A systematic review of the role of the pharmacist. Drugs and Aging 2003;20(11):817-32.
51. Sloane PD, Zimmerman S, Brown LC, Ives TJ, Walsh J. Inappropriate medication prescribing in residential care/ assisted living facilities. Journal of the American Geriatrics Society 2002;50(6):1001-11.
52. Soe A, Apampa B, Fernando B, Thayyil S, Neubert A, Ghaleb MA. Interventions for reducing medication errors in children in hospital. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD006208]
53. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised?. Lancet 2007; 370(9582):173-84.
54. United Nations. World Population Ageing. 2009.
55. Verrue CL, Petrovic M, Mehuys E, Remon JP, Vander Stichele R. Pharmacists' interventions for optimization of medication use in nursing homes: a systematic review. Drugs & Aging 2009;26:37-49.
56. Zermansky AG, Alldred DP, Petty DR, Raynor DK, Freemantle N, Eastaugh J, et al. Clinical medication review by a pharmacist of elderly people living in care homes - randomised controlled trial. Age and Ageing 2006;35: 586-91.